1030 related articles for article (PubMed ID: 31134052)
1. Opposite Profiles of Complement in Antiphospholipid Syndrome (APS) and Systemic Lupus Erythematosus (SLE) Among Patients With Antiphospholipid Antibodies (aPL).
Savelli SL; Roubey RAS; Kitzmiller KJ; Zhou D; Nagaraja HN; Mulvihill E; Barbar-Smiley F; Ardoin SP; Wu YL; Yu CY
Front Immunol; 2019; 10():885. PubMed ID: 31134052
[TBL] [Abstract][Full Text] [Related]
2. The value of IgA antiphospholipid testing for diagnosis of antiphospholipid (Hughes) syndrome in systemic lupus erythematosus.
Bertolaccini ML; Atsumi T; Escudero Contreras A; Khamashta MA; Hughes GR
J Rheumatol; 2001 Dec; 28(12):2637-43. PubMed ID: 11764209
[TBL] [Abstract][Full Text] [Related]
3. MHC studies of the primary antiphospholipid antibody syndrome and of antiphospholipid antibodies in systemic lupus erythematosus.
Goldstein R; Moulds JM; Smith CD; Sengar DP
J Rheumatol; 1996 Jul; 23(7):1173-9. PubMed ID: 8823688
[TBL] [Abstract][Full Text] [Related]
4. The Complex Relationship between C4b-Binding Protein, Warfarin, and Antiphospholipid Antibodies.
Grosso G; Sandholm K; Antovic A; Gunnarsson I; Zickert A; Vikerfors A; Truedsson L; Bruzelius M; Nilsson B; Nilsson-Ekdahl K; Svenungsson E
Thromb Haemost; 2021 Oct; 121(10):1299-1309. PubMed ID: 33412597
[TBL] [Abstract][Full Text] [Related]
5. Autoantibodies to beta2-glycoprotein I in systemic lupus erythematosus and primary antiphospholipid antibody syndrome: clinical correlations in comparison with other antiphospholipid antibody tests.
Day HM; Thiagarajan P; Ahn C; Reveille JD; Tinker KF; Arnett FC
J Rheumatol; 1998 Apr; 25(4):667-74. PubMed ID: 9558167
[TBL] [Abstract][Full Text] [Related]
6. Low copy numbers of complement C4 and homozygous deficiency of C4A may predispose to severe disease and earlier disease onset in patients with systemic lupus erythematosus.
Jüptner M; Flachsbart F; Caliebe A; Lieb W; Schreiber S; Zeuner R; Franke A; Schröder JO
Lupus; 2018 Apr; 27(4):600-609. PubMed ID: 29050534
[TBL] [Abstract][Full Text] [Related]
7. Antiphospholipid antibodies and non-thrombotic manifestations of systemic lupus erythematosus.
İlgen U; Yayla ME; Ateş A; Okatan İE; Yurteri EU; Torgutalp M; Keleşoğlu ABD; Turgay TM; Kınıklı G
Lupus; 2018 Apr; 27(4):665-669. PubMed ID: 29050535
[TBL] [Abstract][Full Text] [Related]
8. Low C4, C4A and C4B gene copy numbers are stronger risk factors for juvenile-onset than for adult-onset systemic lupus erythematosus.
Pereira KM; Faria AG; Liphaus BL; Jesus AA; Silva CA; Carneiro-Sampaio M; Andrade LE
Rheumatology (Oxford); 2016 May; 55(5):869-73. PubMed ID: 26800705
[TBL] [Abstract][Full Text] [Related]
9. Effects of Complement C4 Gene Copy Number Variations, Size Dichotomy, and C4A Deficiency on Genetic Risk and Clinical Presentation of Systemic Lupus Erythematosus in East Asian Populations.
Chen JY; Wu YL; Mok MY; Wu YJ; Lintner KE; Wang CM; Chung EK; Yang Y; Zhou B; Wang H; Yu D; Alhomosh A; Jones K; Spencer CH; Nagaraja HN; Lau YL; Lau CS; Yu CY
Arthritis Rheumatol; 2016 Jun; 68(6):1442-1453. PubMed ID: 26814708
[TBL] [Abstract][Full Text] [Related]
10. Gene copy-number variation and associated polymorphisms of complement component C4 in human systemic lupus erythematosus (SLE): low copy number is a risk factor for and high copy number is a protective factor against SLE susceptibility in European Americans.
Yang Y; Chung EK; Wu YL; Savelli SL; Nagaraja HN; Zhou B; Hebert M; Jones KN; Shu Y; Kitzmiller K; Blanchong CA; McBride KL; Higgins GC; Rennebohm RM; Rice RR; Hackshaw KV; Roubey RA; Grossman JM; Tsao BP; Birmingham DJ; Rovin BH; Hebert LA; Yu CY
Am J Hum Genet; 2007 Jun; 80(6):1037-54. PubMed ID: 17503323
[TBL] [Abstract][Full Text] [Related]
11. Insights on the relationship between complement component C4 serum concentrations and C4 gene copy numbers in a Western Australian systemic lupus erythematosus cohort.
Margery-Muir AA; Bundell C; Wetherall JD; Whidborne R; Martinez P; Groth DM
Lupus; 2018 Sep; 27(10):1687-1696. PubMed ID: 30041577
[TBL] [Abstract][Full Text] [Related]
12. Blood Cell-Bound C4d as a Marker of Complement Activation in Patients With the Antiphospholipid Syndrome.
Lonati PA; Scavone M; Gerosa M; Borghi MO; Pregnolato F; Curreli D; Podda G; Femia EA; Barcellini W; Cattaneo M; Tedesco F; Meroni PL
Front Immunol; 2019; 10():773. PubMed ID: 31031764
[TBL] [Abstract][Full Text] [Related]
13. The prevalence of antibodies to anionic phospholipids in patients with the primary antiphospholipid syndrome, systemic lupus erythematosus and their relatives and spouses.
Radway-Bright EL; Ravirajan CT; Isenberg DA
Rheumatology (Oxford); 2000 Apr; 39(4):427-31. PubMed ID: 10817777
[TBL] [Abstract][Full Text] [Related]
14. Thrombotic risk assessment in antiphospholipid syndrome: do noncriteria antibodies contribute?
Uludağ Ö; Çinar S; McDonnell T; Çene E; Yalçinkaya Y; Gül A; Inanç M; Artim Esen B
Turk J Med Sci; 2023; 53(5):1067-1074. PubMed ID: 38813003
[TBL] [Abstract][Full Text] [Related]
15. Antiphospholipid antibodies (aPL) in systemic lupus erythematosus. Are they specific tools for the diagnosis of aPL syndrome?
Ghirardello A; Doria A; Ruffatti A; Rigoli AM; Vesco P; Calligaro A; Gambari PF
Ann Rheum Dis; 1994 Feb; 53(2):140-2. PubMed ID: 8129460
[TBL] [Abstract][Full Text] [Related]
16. Antiphospholipid syndrome nephropathy in patients with systemic lupus erythematosus and antiphospholipid antibodies: prevalence, clinical associations, and long-term outcome.
Tektonidou MG; Sotsiou F; Nakopoulou L; Vlachoyiannopoulos PG; Moutsopoulos HM
Arthritis Rheum; 2004 Aug; 50(8):2569-79. PubMed ID: 15334471
[TBL] [Abstract][Full Text] [Related]
17. [Leiden, G20210A mutations in prothrombin gene and antiphospholipid antibodies in systemic lupus erythematosus and antiphospholipid syndrome].
Reshetniak TM; Patrushev LI; Stukacheva EA; Miroshnikov AI; Tikhonova TL; Nasonov EL; Alekberova ZS
Ter Arkh; 2000; 72(5):34-8. PubMed ID: 11109617
[TBL] [Abstract][Full Text] [Related]
18. Impact of C4, C4A and C4B gene copy number variation in the susceptibility, phenotype and progression of systemic lupus erythematosus.
Pereira KMC; Perazzio S; Faria AGA; Moreira ES; Santos VC; Grecco M; da Silva NP; Andrade LEC
Adv Rheumatol; 2019 Aug; 59(1):36. PubMed ID: 31387635
[TBL] [Abstract][Full Text] [Related]
19. Anti-heparin platelet factor 4 antibodies in systemic lupus erythematosus are associated with IgM antiphospholipid antibodies and the antiphospholipid syndrome.
Alpert D; Mandl LA; Erkan D; Yin W; Peerschke EI; Salmon JE
Ann Rheum Dis; 2008 Mar; 67(3):395-401. PubMed ID: 17644539
[TBL] [Abstract][Full Text] [Related]
20. Elevated partial antiphospholipid score is a strong risk factor for thrombosis in patients with systemic lupus erythematosus: a validation study.
Chen J; Sun S; Yan Q; Bao C; Fu Q
Clin Rheumatol; 2016 Feb; 35(2):333-40. PubMed ID: 26753544
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
